AMLX logo

Amylyx Pharmaceuticals, Inc. (AMLX) Accounts receivable

Annual accounts receivable:

$447.00K-$39.60M(-98.88%)
December 31, 2024

Summary

  • As of today (September 18, 2025), AMLX annual accounts receivable is $447.00 thousand, with the most recent change of -$39.60 million (-98.88%) on December 31, 2024.
  • During the last 3 years, AMLX annual accounts receivable has risen by +$447.00 thousand (+100.00%).
  • AMLX annual accounts receivable is now -98.88% below its all-time high of $40.05 million, reached on December 31, 2023.

Performance

AMLX Accounts receivable Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Range

Earnings dates

OtherAMLXbalance sheet metrics

Quarterly accounts receivable:

$103.00K-$197.00K(-65.67%)
June 1, 2025

Summary

  • As of today (September 18, 2025), AMLX quarterly accounts receivable is $103.00 thousand, with the most recent change of -$197.00 thousand (-65.67%) on June 1, 2025.
  • Over the past year, AMLX quarterly accounts receivable has dropped by -$3.99 million (-97.48%).
  • AMLX quarterly accounts receivable is now -99.74% below its all-time high of $40.05 million, reached on December 31, 2023.

Performance

AMLX Quarterly accounts receivable Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Range

Earnings dates

OtherAMLXbalance sheet metrics

Accounts receivable Formula

Accounts Receivable = Total Credit Sales − Amount Collected from Credit Sales

AMLX Accounts receivable Trends

PeriodPeriodAnnualAnnualQuarterlyQuarterly
1 y1 year-98.9%-97.5%
3 y3 years+100.0%-
5 y5 years--

AMLX Accounts receivable Highs & Lows

PeriodPeriodAnnual vs highAnnual vs highAnnual vs lowAnnual vs lowQuarter. vs highQuarter. vs highQuarter. vs lowQuarter. vs low
3 y3-year-98.9%>+9999.0%-99.7%at low
5 y5-year-98.9%>+9999.0%-99.7%>+9999.0%
alltimeall time-98.9%>+9999.0%-99.7%>+9999.0%

AMLX Accounts receivable History

DateAnnualQuarterly
Jun 2025
-
$103.00K(-65.7%)
Mar 2025
-
$300.00K(-32.9%)
Dec 2024
$447.00K(-98.9%)
$447.00K(-74.2%)
Sep 2024
-
$1.73M(-57.7%)
Jun 2024
-
$4.09M(-79.9%)
Mar 2024
-
$20.35M(-49.2%)
DateAnnualQuarterly
Dec 2023
$40.05M(+161.7%)
$40.05M(+36.4%)
Sep 2023
-
$29.35M(-12.3%)
Jun 2023
-
$33.47M(+90.7%)
Mar 2023
-
$17.55M(+14.7%)
Dec 2022
$15.31M(>+9900.0%)
$15.31M(>+9900.0%)
Sep 2022
-
$137.00K(>+9900.0%)
Dec 2021
$0.00
$0.00

FAQ

  • What is Amylyx Pharmaceuticals, Inc. annual accounts receivable?
  • What is the all time high annual accounts receivable for Amylyx Pharmaceuticals, Inc.?
  • What is Amylyx Pharmaceuticals, Inc. annual accounts receivable year-on-year change?
  • What is Amylyx Pharmaceuticals, Inc. quarterly accounts receivable?
  • What is the all time high quarterly accounts receivable for Amylyx Pharmaceuticals, Inc.?
  • What is Amylyx Pharmaceuticals, Inc. quarterly accounts receivable year-on-year change?

What is Amylyx Pharmaceuticals, Inc. annual accounts receivable?

The current annual accounts receivable of AMLX is $447.00K

What is the all time high annual accounts receivable for Amylyx Pharmaceuticals, Inc.?

Amylyx Pharmaceuticals, Inc. all-time high annual accounts receivable is $40.05M

What is Amylyx Pharmaceuticals, Inc. annual accounts receivable year-on-year change?

Over the past year, AMLX annual accounts receivable has changed by -$39.60M (-98.88%)

What is Amylyx Pharmaceuticals, Inc. quarterly accounts receivable?

The current quarterly accounts receivable of AMLX is $103.00K

What is the all time high quarterly accounts receivable for Amylyx Pharmaceuticals, Inc.?

Amylyx Pharmaceuticals, Inc. all-time high quarterly accounts receivable is $40.05M

What is Amylyx Pharmaceuticals, Inc. quarterly accounts receivable year-on-year change?

Over the past year, AMLX quarterly accounts receivable has changed by -$3.99M (-97.48%)
On this page